PHARMADEV PHARMA-DEV

Publications MRN2i




  • Abravanel F, Lacipière A, Lhomme S, Dubois M, Minier L, Peron JM, Alric L, Kamar N, Izopet J. Performance of a commercial assay for detecting and quantifying HEV RNA in faeces. (2018). J Clin Virol. 109:1-5.
  • Ala Eddine M, Prat M, Poinsot V, Gouazé-Anderson V, Authier H, Meunier E, Lefèvre L, Dardenne C, Bernad J, Alric L, Ségui B, Balard P, Couderc F, Couderc B, Pipy B, Coste A. IL-13-mediated Dectin-1 and Mannose Receptor overexpression promotes antitumor activities of tumor-associated macrophages through the recognition of sialylated tumor cells. (2018). Cancer Immunology research. In press IF=9.18
  • Ali AM, Penny MA, Smith TA, Workman L, Sasi P, Adjei GO, Aweeka F, Kiechel JR, Jullien V, Rijken MJ, McGready R, Mwesigwa J, Kristensen K, Stepniewska K, Tarning J, Barnes KI, Denti P; WWARN Amodiaquine PK Study Group. Population Pharmacokinetics of the Antimalarial Amodiaquine: a Pooled Analysis To Optimize Dosing. (2018) Antimicrob Agents Chemother. 62(10). IF=4.25
  • Allaire M, Cadranel JD, Bureau C, Zerkly S, Thévenot T, Garioud A, Cacoub P, Macaigne G, Alric L, Jouannaud V, Lison H, Chagneau-Derrode C, Pariente A, Pe Combining Acute Accent Laquier ACGAS, Bourlie Combining Grave Accent Re M, Causse X, Nousbaum JB, Dumortier JCAAR, Louvet A, Rosa-He Combining Acute Accent Zode I, Ganne-Carrie Combining Acute Accent N, Chentouh R, Sfaxi A, Gournay JCAAR, Blasco-Perrin HCAALCGAN, Antonini T, Spahr L, Bronowicki JP, Silvain C, Di Martino V, Grange JD, Denis J, Dupont K, Iaria P, Ollivier-Hourmand I, Dao T; French association of gastroenterologist and hepatologist from primary hospital (ANGH). Severe liver failure rather than cirrhosis is associated with mortality in patients with infectious endocarditis: a retrospective case-control study. (2018). Eur J Gastroenterol Hepatol. 30(10):1216-1223.
  • Allaire M, Nahon P, Layese R, Bourcier V, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, Zarski JP, Riachi G,Calès P, Péron JM, Alric L, Bourlière M, Mathurin P, Blanc JF, Abergel A, Serfaty L, Mallat A, Grangé JD, Attali P, Bacq Y, Wartelle C, Dao T, Thabut D, Pilette C, Silvain C, Christidis C, Nguyen-Khac E, Bernard-Chabert B, Zucman D, DI Martino V, Sutton A, Letouzé E, Audureau E, Roudot-Thoraval F; ANRS CO12 CirVir Group. Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradication. (2018). Hepatology. 68(4):1245-1259.
  • Alric L, Ollivier-Hourmand I, Bérard E, Hillaire S, Guillaume M, Vallet-Pichard A, Bernard- Chabert B, Loustaud-Ratti V, Bourlière M, de Ledinghen V, Fouchard-Hubert I, Canva V, Minello A, Nguyen-Khac E, Leroy V, Saadoun D, Trias D, Pol S, Kamar N. Grazoprevir plus elbasvir in HCV genotype-1 or -4 infected patients with stage 4/5 severe chronic kidney disease is safe and effective. (2018). Kidney Int. 94(1):206-213.
  • Brichler S, Nahon P, Zoulim F, Layese R, Bourcier V, Audureau E, Sutton A, Letouze E, Cagnot C, Marcellin P, Guyader D, Roulot D, Pol S, de Ledinghen V, Zarski JP, Calès P, Tran A, Peron JM, Mallat A, Riachi G, Grange JD, Blanc JF, Bacq Y, Ouzan D, Bronowicki JP, Mathurin P, Larrey D, Alric L, Attali P, Serfaty L, Pilette C, Bourlière M, Thabut D, Silvain C, Wartelle C, Zucman D, Christidis C, Roudot-Thoraval F, Ganne-Carrie N; ANRS CO12 CirVir study group. Non-virological factors are drivers of Hepatocellular Carcinoma in virosuppressed Hepatitis B cirrhosis: results of ANRS CO12 CirVir cohort. (2018). J Viral Hepat. doi: 10.1111/jvh.13029
  • Cacoub P, Si Ahmed SN, Ferfar Y, Pol S, Thabut D, Hezode C, Alric L, Comarmond C, Ragab G, Quartuccio L, Hegazy M, Poynard T, Resche Rigon M, Saadoun D. Long-Term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus- Associated Cryoglobulinemia Vasculitis. (2018). Clin Gastroenterol Hepatol. S1542- 3565(18)30553-6.
  • Clerc P, Jeanjean P, Hallali N, Gougeon M, Pipy B, Carrey J, Fourmy D, Gigoux V. Targeted Magnetic Intra-Lysosomal Hyperthermia produces lysosomal reactive oxygen species and causes Caspase-1 dependent cell death. J Control Release. 2018 Jan 28;270:120-134.
  • Costentin CE, Layese R, Bourcier V, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, Zarski JP, Riachi G, Calès P, Péron JM, Alric L, Bourlière M, Mathurin P, Blanc JF, Abergel A, Serfaty L, Mallat A, Grangé JD, Attali P, Bacq Y, Wartelle C, Dao T, Thabut D, Pilette C, Silvain C, Christidis C, Nguyen-Khac E, Bernard-Chabert B, Zucman D, Di Martino V, Sutton A, Letouzé E, Imbeaud S, Zucman-Rossi J, Audureau E, Roudot-Thoraval F, Nahon P; ANRS CO12 CirVir Group. Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study. (2018). Gastroenterology. 155(2):431-442.e10.
  • Denadai-Souza A, Bonnart C, Tapias NS, Marcellin M, Gilmore B, Alric L, Bonnet D, Burlet- Schiltz O, Hollenberg MD, Vergnolle N, Deraison C. Functional Proteomic Profiling of Secreted Serine Proteases in Health and Inflammatory Bowel Disease. (2018). Sci Rep. 8(1):7834.
  • Desbois AC, Biard L, Addimanda O, Lambert M, Hachulla E, Launay D, Ackermann F, Pérard L, Hot A, Maurier F, Mausservey C, Bernard F, Noel N, Alric L, Mirault T, Cohen F, Boussouar S, Resche-Rigon M, Cacoub P, Saadoun D. Efficacy of anti-TNF alpha in severe and refractory major vessel involvement of Behcet’s disease: A multicenter observational study of 18 patients. (2018). Clin Immunol. 197:54-59.
  • Dion J, Malphettes M, Bénéjat L, Mégraud F, Wargnier A, Boutboul D, Galicier L, Le Moing V, Giraud P, Jaccard A, Nove-Josserand R, Fieschi C, Oksenhendler E, Gérard L; DEFI study group. Campylobacter infection in adult patients with primary antibody deficiency. (2018). J Allergy Clin Immunol Pract. S2213-2198.
  • Dupont R, Longué M, Galinier A, Cinq Frais C, Ingueneau C, Astudillo L, Arlet P, Adoue D, Alric L, Prévot G, Cabarrou B, Sailler L, Pugnet G. Impact of micronutrient deficiency & malnutrition in systemic sclerosis: Cohort study and literature review. (2018). Autoimmun Rev. 17(11):1081-1089.
  • Garnier C, Ribes D, Chauveau D, Huart A, Pugnet G, Adoue D, Prevot G, Alric L, Delobel P, Derumeaux H, Mengelle C, Sailler L, Moulis G. Zoster after Cyclophosphamide for Systemic Lupus Erythematosus or Vasculitis: Incidence, Risk Factors, and Effect of Antiviral Prophylaxis. (2018). J Rheumatol. 45(11):1541-1548.
  • Girard M, Poujois A, Fabre M, Lacaille F, Debray D, Rio M, Fenaille F, Cholet S, Ruel C, Caussé E, Selves J, Bridoux-Henno L, Woimant F, Dupré T, Vuillaumier-Barrot S, Seta N, Alric L, de Lonlay P, Bruneel A. CCDC115-CDG: A new rare and misleading inherited cause of liver disease. (2018). Mol Genet Metab. 124(3):228-235.
  • Haidara M, Haddad M, Denou A, Marti G, Bourgeade-Delmas S, Sanogo R, Bourdy G, Aubouy A. In vivo validation of anti-malarial activity of crude extracts of Terminalia macroptera, a Malian medicinal plant. (2018). Malar J. 17(1):68. IF=3.017
  • Halfon P, Scholtès C, Izopet J, Larrat S, Trimoulet P, Zoulim F, Alric L, Métivier S, Leroy V, Ouzan D, de Lédinghen V, Mohamed S, Pénaranda G, Khiri H, Thélu MA, Plauzolles A, Chiche L, Bourlière M, Abravanel F. Baseline and post-treatment hepatitis C NS5A resistance in relapsed patients from a multicentric real-life cohort. (2018). Antivir Ther. 23(4):307-314.
  • Lallemand T, Rouahi M, Swiader A, Grazide MH, Geoffre N, Alayrac P, Recazens E, Coste A, Salvayre R, Nègre-Salvayre A, Augé N. nSMase2 (Type 2-Neutral Sphingomyelinase) Deficiency or Inhibition by GW4869 Reduces Inflammation and Atherosclerosis in Apoe-/- Mice. (2018). Arterioscler Thromb Vasc Biol. 38(7):1479-1492. IF=6.08
  • Marion O, Abravanel F, Del Bello A, Esposito L, Lhomme S, Puissant-Lubrano B, Alric L, Faguer S, Izopet J, Kamar N. Hepatitis E virus-associated cryoglobulinemia in solid-organ- transplant recipients. (2018). Liver Int. 38(12):2178-2189.
  • Mekinian A, Resche-Rigon M, Comarmond C, Soriano A, Constans J, Alric L, Jego P, Busato F, Cabon M, Dhote R, Estibaliz L, Koné-Paut I, Landron C, Lavigne C, Lioger B, Michaud M, Ruivard M, Sacre K, Gottenberg JE, Gaches F, Goulenok T, Salvarani C, Cacoub P, Fain O, Saadoun D; French Takayasu network. Efficacy of tocilizumab in Takayasu arteritis: Multicenter retrospective study of 46 patients. (2018). J Autoimmun. 91:55-60.
  • Merli M, Frigeni M, Alric L, Visco C, Besson C, Mannelli L, Di Rocco A, Ferrari A, Farina L, Pirisi M, Piazza F, Loustaud-Ratti V, Arcari A, Marino D, Sica A, Goldaniga M, Rusconi C, Gentile M, Cencini E, Benanti F, Rumi MG, Ferretti VV, Grossi P, Gotti M, Sciarra R, Tisi MC, Cano I, Zuccaro V, Passamonti F, Arcaini L. Direct-Acting Antivirals in Hepatitis C Virus- Associated Diffuse Large B-cell Lymphomas. (2018). Oncologist. Dec 14. doi: 10.1634/theoncologist.2018-0331
  • Mourguet M, Chauveau D, Faguer S, Ruidavets JB, Béjot Y, Ribes D, Huart A, Alric L, Balardy L, Astudillo L, Adoue D, Sailler L, Pugnet G. Increased ischemic stroke, acute coronary artery disease and mortality in patients with granulomatosis with polyangiitis and microscopic polyangiitis. (2018). J Autoimmun. S0896-8411(18)30411-6.
  • Nahon P, Layese R, Bourcier V, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, Zarski JP, Riachi G, Calès P, Péron JM, Alric L, Bourlière M, Mathurin P, Blanc JF, Abergel A, Serfaty L, Mallat A, Grangé JD, Attali P, Bacq Y, Wartelle C, Dao T, Thabut D, Pilette C, Silvain C, Christidis C, Nguyen-Khac E, Bernard-Chabert B, Zucman D, Di Martino V, Sutton A, Roudot-Thoraval F, Audureau E; ANRS CO12 CirVir Group. Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs. (2018). Gastroenterology. 155(5):1436-1450.
  • Nordmann S, Vilotitch A, Roux P, Esterle L, Spire B, Marcellin F, Salmon-Ceron D, Dabis F, Chas J, Rey D, Wittkop L, Sogni P, Carrieri P; ANRS CO13 HEPAVIH Study Group. Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus-co-infected patients (ANRS CO13-HEPAVIH). (2018). J Viral Hepat. 25(2):171-179.
  • Piel-Julian ML, Mahévas M, Germain J, Languille L, Comont T, Lapeyre-Mestre M, Payrastre B, Beyne-Rauzy O, Michel M, Godeau B, Adoue D, Moulis G; CARMEN investigators group. Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults. (2018). J Thromb Haemost. 16(9):1830-1842.
  • Pradel S, Brun S, Victor G, Pascal P, Fournier P, Ribes D, Lavie-Badie Y, Galinier M, Carrié D, Berry I, Lairez O; Toulouse Amyloidosis Research Network collaborators. Pattern of myocardial 99mTc-HMDP uptake and impact on myocardial function in patients with transthyretin cardiac amyloidosis. (2018). J Nucl Cardiol.
  • Salmon D, Trimoulet P, Gilbert C, Solas C, Lafourcade E, Chas J, Piroth L, Lacombe K, Katlama C, Peytavin G, Aumaitre H, Alric L, Boué F, Morlat P, Poizot-Martin I, Billaud E, Rosenthal E, Naqvi A, Miailhes P, Bani-Sadr F, Esterle L, Carrieri P, Dabis F, Sogni P, Wittkop L; ANRS CO13 Hepavih study Group. Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients. (2018). World J Hepatol. 10(11):856-866.
  • Sébert M, Denadai-Souza A, Quaranta M, Racaud-Sultan C, Chabot S, Lluel P, Monjotin N, Alric L, Portier G, Kirzin S, Bonnet D, Ferrand A, Vergnolle N. Thrombin modifies growth, proliferation and apoptosis of human colon organoids: a protease-activated receptor 1- and protease-activated receptor 4-dependent mechanism. (2018). Br J Pharmacol. 175(18):3656- 3668.





  • Armengol C., Cassaing S., Roques-Malecaze C., Chauvin P., Iriart X., Berry A., Fillaux J. (2017). Time before anti-Toxoplasma IgG seroconversion detection by 7 commercial assays in French pregnant women. Diagnostic Microbiology and Infectious Disease, 87 (2), 103-107.
  • Benmoussa K., Authier H., Prat M., AlaEddine M., Lefevre L., Rahabi M. C., Bernad J., Aubouy A, Bonnafe E., Leprince J., Pipy B., Treilhou M., Coste A. (2017). P17, an original host defense peptide from ant venom, promotes antifungal activities of macrophages through the induction of C-type lectin receptors dependent on LTB4-mediated PPAR gamma activation. Frontiers in Immunology, 8.
  • Bourlière M, Gordon SC, Flamm SL, Cooper CL, Ramji A, Tong M, Ravendhran N, Vierling JM, Tran TT, Pianko S, Bansal MB, de Lédinghen V, Hyland RH, Stamm LM1, Dvory-Sobol H, Svarovskaia E, Zhang J, Huang KC, Subramanian GM, Brainard DM, McHutchison JG1, Verna EC1, Buggisch P, Landis CS, Younes ZH, Curry MP, Strasser SI, Schiff ER, Reddy KR, Manns MP, Kowdley KV, Zeuzem S; POLARIS-1 and POLARIS-4 Investigators. Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection. N Engl J Med. 2017 Jun 1;376(22):2134-2146.
  • Bourlière M, Rabiega P, Ganne-Carrie N, Serfaty L, Marcellin P, Barthe Y, Thabut D, Guyader D, Hezode C, Picon M, Causse X, Leroy V, Bronowicki JP, Carrieri P, Riachi G, Rosa I, Attali P, Molina JM, Bacq Y, Tran A, Grangé JD, Zoulim F, Fontaine H, Alric L, Bertucci I, Bouvier-Alias M, Carrat F; ANRS HB06 PEGAN Study Group. Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trial. Lancet Gastroenterol Hepatol. 2017 Mar;2(3):177-188.
  • Comarmond C, Garrido M, Pol S, Desbois AC, Costopoulos M, Le Garff-Tavernier M, Si Ahmed SN5, Alric L, Fontaine H, Bellier B, Maciejewski A, Rosenzwajg M, Klatzmann D, Musset L, Poynard T8, Cacoub P1, Saadoun D Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis. Gastroenterology. 2017 Jun;152(8):2052-2062.e2
  • Dumortier J., Bailly F., Pageaux G. P., Vallet-Pichard A., Radenne S., Habersetzer F., Gagnieu M. C., Grange J. D., Minello A., Guillaud O., Kamar N., Alric L., Leroy V. (2017). Sofosbuvir-based antiviral therapy in hepatitis C virus patients with severe renal failure. Nephrology Dialysis Transplantation, 32 (12), 2065-2071.
  • Fontaine H., Maynard M., Bouix C., Carrieri M. P., Botta-Fridlund D., D’Alteroche L., Conti F., Pageaux G. P., Leroy V., Metivier S., Anty R., Durand F., Canva V., Vilotitch A., Lebray P., Alric L., Duvoux C., Petrov-Sanchez V., Beaulieux F., Wellems C., Paul C., Roque-Afonso A. M., Roche B., Pradat P., Samuel D., Duclos-Vallee J. C., Bailly F., Dharancy S., Grange J. D., Guidoum A., Hezode C., Serfaty A., Si-Ahmeda S. N., Sizorn M., Taburet A. M., Teicher E., Bocepretransplant Study Grp. (2017). Efficacy and safety of boceprevir-based triple therapy in HCV cirrhotic patients awaiting liver transplantation (ANRS HC29 BOCEPRETRANSPLANT). Clinics and Research in Hepatology and Gastroenterology, 41 (1), 56-65.
  • Garioud A1, Cadranel JF, Pauwels A, Nousbaum JB, Thévenot T, Dao T, Louvet A, Sogni P, Talbodec N, Antonini TM, Bureau C, Thabut D, Elkrief L, Jouannaud V, Macaigne G, Bernard-Chabert B, Lison H, Alric L, Carbonell N, Labadie H, Amiot X, Abergel A, Hanslik B, Leroy V, De Lédinghen V, Denis J; Association Nationale des Hépato-gastroentérologues des Hôpitaux Généraux de France, Association Française pour l'Etude du Foie, Club de Réflexion des Cabinets et Groupes d'Hépato-Gastroentérologie. Albumin Use in Patients With Cirrhosis in France: Results of the “ALBU-LIVE” Survey: A Case for Better EASL Guidelines Diffusion and/or Revision. J Clin Gastroenterol. 2017 Oct;51(9):831-838.
  • Gobbetti T, Dalli J, Colas RA, Federici Canova D, Aursnes M, Bonnet D, Alric L, Vergnolle N, Deraison C, Hansen TV, Serhan CN, Perretti M. Protectin D1n-3 DPA and resolvin D5n-3 DPA are effectors of intestinal protection. Proc Natl Acad Sci U S A. 2017 Apr 11;114(15):3963-3968
  • Halfon P, Scholtès C, Izopet J, Larrat S, Trimoulet P, Zoulim F, Alric L, Métivier S, Leroy V, Ouzan D, de Lédinghen V, Mohamed S, Pénaranda G, Khiri H, Thélu MA, Plauzolles A, Chiche L, Bourlière M, Abravanel F. Retreatment with direct-acting antivirals of genotypes 1- 3-4 hepatitis C patients who failed an anti-NS5A regimen in real world. (2017). J Hepatol. S0168-8278(17)32333-4.
  • Magnaval JF, Laurent G, Gaudré N, Fillaux J, Berry A. A diagnostic protocol designed for determining allergic causes in patients with blood eosinophilia. (2017). Mil Med Res.
  • Nahon P, Bourcier V, Layese R, Audureau E, Cagnot C, Marcellin P, Guyader D, Fontaine H, Larrey D, de Ledinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, Zarski JP, Leroy V, Riachi G, Cales P, Peron JM, Alric L, Bourliere M, Mathurin P, Dharancy S, Blanc JF, Abergel A, Serfaty L, Mallat A, Grange JD, Attali P, Bacq Y, Wartelle C, Dao T, Benhamou Y, Pilette C, Silvain C, Christidis C, Capron D, Bernard-Chabert B, Zucman D, Di Martino V, Thibaut V, Salmon D, Ziol M, Sutton A, Pol S, Roudot-Thoraval F. (2017). Eradication of Hepatitis C Virus Infection in Patients
  • With Cirrhosis Reduces Risk of Liver and Non-Liver Complications. GASTROENTEROLOGY, 152 (1), 142-+.
  • Nahon P, Lescat M, Layese R, Bourcier V, Talmat N, Allam S, Marcellin P, Guyader D, Pol S, Larrey D, De Ledinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, Zarski JP, Goria O, Cales P, Peron JM, Alric L, Bourliere M, Mathurin P, Blanc JF, Abergel A, Serfaty L, Mallat A, Grange JD, Attali P, Bacq Y, Wartelle C, Dao T, Benhamou Y, Pilette C, Silvain C, Christidis C, Capron D, Bernard-Chabert B, Hillaire S, Di Martino V, Trinchet JC, Moreau R, Roudot-Thoraval F. (2017). Bacterial infection in compensated viral cirrhosis impairs 5-year survival (ANRS CO12 CirVir prospective cohort). GUT, 66 (2), 330-341.
  • Pineton de Chambrun M, Gousseff M, Mauhin W, Lega JC, Lambert M, Rivière S, Dossier A, Ruivard M, Lhote F, Blaison G, Alric L, Agard C, Saadoun D, Graveleau J, Soubrier M, Lucchini-Lecomte MJ, Christides C, Bosseray A, Levesque H, Viallard JF, Tieulie N, Lovey PY, Le Moal S, Bibes B, Malizia G, Abgueguen P, Lifermann F, Ninet J, Hatron PY, Amoura Z; Euré‚Clark Study Group. Intravenous Immunoglobulins Improve Survival in Monoclonal Gammopathy-Associated Systemic Capillary-Leak Syndrome. (2017). Am J Med. 130(10):1219.e19-1219.e
  • Pineton de Chambrun M, Luyt CE, Beloncle F, Gousseff M, Mauhin W, Argaud L, Ledochowski S, Moreau AS, Sonneville R, Verdière B, Merceron S, Zappella N, Landais M, Contou D, Demoule A, Paulus S, Souweine B, Lecomte B, Vieillard-Baron A, Terzi N, Azoulay E, Friolet R, Puidupin M, Devaquet J, Mazou JM, Fedun Y, Mira JP, Raphalen JH, Combes A, Amoura Z; Euré‚Clark Study Group. The Clinical Picture of Severe Systemic Capillary-Leak Syndrome Episodes Requiring ICU Admission. (2017). Crit Care Med. 45(7):1216-1223.
  • Piroth L., Wittkop L., Lacombe K., Rosenthal E., Gilbert C., Miailhes P., Carrieri P., Chas J., Poizot-Martin I., Gervais A., Dominguez S., Neau D., Zucman D., Billaud E., Morlat P., Aumaitre H., Lascoux-Combe C., Simon A., Bouchaud O., Teicher E., Bani-Sadr F., Alric L., Vittecoq D., Boue F., Duvivier C., Valantin M. A., Esterle L., Dabis F., Sogni P., Salmon D., Anrs Co Hepavih Study Grp. (2017). Efficacy and safety of direct-acting antiviral regimens in HIV/HCV-co-infected patients – French ANRS CO13 HEPAVIH cohort. Journal of Hepatology, 67 (1), 23-31.
  • Pol S., Bourliere M., Lucier S., Hezode C., Dorival C., Larrey D., Bronowicki J. P., Ledinghen V. D. E., Zoulim F., Tran A., Metivier S., Zarski J. P., Samuel D., Guyader D., Marcellin P., Minello A., Alric L., Thabut D., Chazouilleres O., Riachi G., Bourcier V., Mathurin P., Loustaud-Ratti V., D’Alteroche L., Fouchard-Hubert I., Habersetzer F., Causse X., Geist C., Rosa I., Gournay J., Saillard E., Billaud E., Petrov-Sanchez V., Diallo A., Fontaine H., Carrat F., Anrs Afef Hepather Study Grp. (2017). Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients. Journal of Hepatology, 66 (1), 39-47.
  • Wyles D, Poordad F, Wang S, Alric L, Felizarta F, Kwo PY, Maliakkal B, Agarwal K, Hassanein T, Weilert F, Lee SS, Kort J, Lovell SS, Liu R, Lin CW, Pilot-Matias T, Krishnan P, Mensa FJ. Glecaprevir/Pibrentasvir for HCV Genotype 3 Patients with Cirrhosis and/or Prior Treatment Experience: A Partially Randomized Phase III Clinical Trial. (2017). Hepatology
  • Zhou X, Huang F, Xu L, Lin Z, de Vrij FMS, Ayo-Martin AC, van der Kroeg M, Zhao M, Yin Y, Wang W, Cao W, Wang Y, Kushner SA, Marie Peron J, Alric L, de Man RA, Jacobs BC, van Eijk JJ, Aronica EMA, Sprengers D, Metselaar HJ, de Zeeuw CI, Dalton HR, Kamar N, Peppelenbosch MP, Pan Q. Hepatitis E Virus Infects Neurons and Brains. (2017). J Infect Dis. 215(8):1197-1206.





  • Abravanel F, Barrague H, Dorr G, Saune K, Peron JM, Alric L, Kamar N, Izopet J, Champagne E. (2016). Conventional and innate lymphocytes response at the acute phase of HEV infection in transplanted patients. JOURNAL OF INFECTION, 72 (6), 723-730.
  • Alric L., Besson C., Lapidus N., Jeannel J., Michot J. M., Cacoub P., Canioni D., Pol S., Davi F., Rabiega P., Ysebaert L., Bonnet D., Hermine O. (2016). Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study. Plos One, 11 (10).
  • Alric L., Bonnet D. (2016). Grazoprevir + elbasvir for the treatment of hepatitis C virus infection. Expert Opinion on Pharmacotherapy, 17 (5), 735-742.
  • Arcaini L., Besson C., Frigeni M., Fontaine H., Goldaniga M., Casato M., Visentini M., Torres H. A., Loustaud-Ratti V., Peveling-Oberhag J., Fabris P., Rossotti R., Zaja F., Rigacci L., Rattotti S., Bruno R., Merli M., Dorival C., Alric L., Jaccard A., Pol S., Carrat F., Ferretti V. V., Visco C., Hermine O. (2016). Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection. Blood, 128 (21), 2527-2532.
  • Berry A., Fillaux J., Martin-Blondel G., Boissier J., Iriart X., Marchou B., Magnaval J., Delobel P. (2016). Evidence for a permanent presence of schistosomiasis in Corsica, France, 2015. Eurosurveillance, 21 (1), 7-10.
  • Canioni D., Michot J. M., Rabiega P., Molina T. J., Charlotte F., Lazure T., Davi F., Settegrana C., Berger F., Alric L., Cacoub P., Terrier B., Suarez F., Sibon D., Dupuis J., Feray C., Tilly H., Pol S., Fischer B. D., Roulland S., Thieblemont C., Leblond V., Carrat F., Hermine O., Besson C., Natl Anrs H. C. LymphoC Study. (2016). In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas. Plos One, 11 (6).
  • Fontaine H., Thervet E., Bonnemains V., Alric L., Boffa J. J., Mathurin P., Stengel B., Carrat F., Pol S., Wittkop L. (2016). Cross-sectional Study of Chronic Kidney Disease Prevalence in association with Monoinfected patients Hepatitis C virus in ANRS CO-22 Hepather cohort. Hepatology, 63 (1 SUPP), 393A-394A.
  • Ganne-Carrie N, Layese R, Bourcier V, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, de Ledinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, Zarski JP, Riachi G, Cales P, Peron JM, Alric L, Bourliere M, Mathurin P, Blanc JF, Abergel A, Serfaty L, Mallat A, Grange JD, Attali P, Bacq Y, Wartelle C, Dao T, Benhamou Y, Pilette C, Silvain C, Christidis C, Capron D, Bernard-Chabert B, Zucman D, Di Martino V, Trinchet JC, Nahon P, Roudot-Thoraval F.  (2016). Nomogram for Individualized Prediction of Hepatocellular Carcinoma Occurrence in Hepatitis C Virus Cirrhosis (ANRS CO12 CirVir). HEPATOLOGY, 64 (4), 1136-1147.
  • Hezode C., Alric L., Brown A., Hassanein T., Rizzetto M., Buti M., Bourliere M., Thabut D., Molina E., Rustgi V., Samuel D., McPhee F., Liu Z. H., Yin P. D., Hughes E., Treitel M., Command- Study Team. (2016). Randomized controlled trial of the NS5A inhibitor daclatasvir plus pegylated interferon and ribavirin for HCV genotype-4 (COMMAND-4). Antiviral Therapy, 21 (3), 195-205.
  • Hurlot Q, Fillaux J, Laurent C, Berry A, Hofman P, Marchou B, Delobel P, Brousset P, Martin-Blondel G. (2016). A case report of isolated lymphadenopathy revealing localized leishmanial lymphadenopathy in an asthenic 25-year-old man. MEDICINE, 95 (29), e
  • Kamar N., Lhomme S., Abravanel F., Marion O., Peron J. M., Alric L., Izopet J. (2016). Treatment of HEV Infection in Patients with a Solid-Organ Transplant and Chronic Hepatitis. Viruses-Basel, 8 (8).
  • Kamar N., Marion O., Rostaing L., Cointault O., Ribes D., Lavayssiere L., Esposito L., Del Bello A., Metivier S., Barange K., Izopet J., Alric L. (2016). Efficacy and Safety of Sofosbuvir-Based Antiviral Therapy to Treat Hepatitis C Virus Infection After Kidney Transplantation. American Journal of Transplantation, 16 (5), 1474-1479.
  • Loiseau C., Requena M., Mavigner M., Cazabat M., Carrere N., Suc B., Barange K., Alric L., Marchou B., Massip P., Izopet J., Delobel P. (2016). CCR6(-) regulatory T cells blunt the restoration of gut Th17 cells along the CCR6-CCL20 axis in treated HIV-1-infected individuals. Mucosal Immunology, 9 (5), 1137-1150.
  • Marion O., Kamar N., Rostaing L., Cointault O., Ribes D., Lavayssiere L., Esposito L., Del Bello A., Metivier S., Barange K., Izopet J., Alric L. (2016). Efficacy and safety of sofosbuvir-based antiviral therapy to treat hepatitis c virus infection after kidney transplantation. Transplant International, 29 (1), 10-10.
  • Millon L, Herbrecht R, Grenouillet F, Morio F, Alanio A, Letscher-Bru V, Cassaing S, Chouaki T, Kauffmann-Lacroix C, Poirier P, Toubas D, Augereau O, Rocchi S, Garcia-Hermoso D, Bretagne S. (2016). Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French Surveillance Network of Invasive Fungal Infections (RESSIF). Clinical microbiology and infection, 22 (9), 810.e
  • Peron JM, Abravanel F, Guillaume M, Gerolami R, Nana J, Anty R, Pariente A, Renou C, Bureau C, Robic MA, Alric L, Vinel JP, Izopet J, Kamar N. (2016). Treatment of autochthonous acute hepatitis E with short-term ribavirin: a multicenter retrospective study. LIVER INTERNATIONAL, 36 (3), 328-333.
  • Poizot-Martin I., Bellissant E., Garraffo R., Colson P., Piroth L., Solas C., Renault A., Bourliere M., Halfon P., Ghosn J., Alric L., Naqvi A., Carrieri P., Molina J. M., Anrs Hc Boceprevih Study Grp. (2016). Addition of boceprevir to PEG-interferon/ribavirin in HIV-HCV-Genotype-1-coinfected, treatment-experienced patients: efficacy, safety, and pharmacokinetics data from the ANRS HC27 study. Hiv Clinical Trials, 17 (2), 63-71.
  • Rostaing L., Alric L., Kamar N. (2016). Use of direct-acting agents for hepatitis C virus-positive kidney transplant candidates and kidney transplant recipients. Transplant International, 29 (12), 1257-1265.
  • Saadoun D, Thibault V, Si Ahmed SN, Alric L, Mallet M, Guillaud C, Izzedine H, Plaisier A, Fontaine H, Costopoulos M, Le Garff-Tavernier M, Hezode C, Pol S, Musset L, Poynard T, Cacoub P. (2016). Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study. ANNALS OF THE RHEUMATIC DISEASES, 75 (10), 1777-1782.
  • Saadoun D, Pol S, Ferfar Y, Alric L, Hezode C, Si Ahmed SN, de Saint Martin L, Comarmond C, Bouyer AS, Musset L, Poynard T, Resche Rigon M, Cacoub P. Efficacy and Safety of Sofosbuvir Plus Daclatasvir for Treatment of HCV-Associated Cryoglobulinemia Vasculitis. Gastroenterology. 2017, 153,49-52.
  • Sogni P, Gilbert C, Lacombe K, Piroth L, Rosenthal E, Miailhes P, Gervais A, Esterle L, Chas J, Poizot-Martin I, Dominguez S, Simon A, Morlat P, Neau D, Zucman D, Bouchaud O, Lascoux-Combe C, Bani-Sadr F, Alric L, Goujard C, Vittecoq D, Billaud E, Aumaitre H, Boue F, Valantin MA, Dabis F, Salmon D, Wittkop L. (2016). All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus-coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13-HEPAVIH Cohort. CLINICAL INFECTIOUS DISEASES, 63 (6), 763-770.
  • Tene N, Bonnafe E, Berger F, Rifflet A, Guilhaudis L, Segalas-Milazzo I, Pipy B, Coste A, Leprince J, Treilhou M. (2016). Biochemical and biophysical combined study of bicarinalin, an ant venom antimicrobial peptide. PEPTIDES, 79, 103-113.
  • Tremeaux P, Lhomme S, Chapuy-Regaud S, Peron JM, Alric L, Kamar N, Izopet J, Abravanel F.  (2016). Performance of an antigen assay for diagnosing acute hepatitis E virus genotype 3 infection. JOURNAL OF CLINICAL VIROLOGY, 79, 1-5.





  • Abgrall S, Rachas A, Tourret J, Isnard-Bagnis C, Billaud E, Tattevin P, Costagliola D, Guiguet M, Durieux P. (2015). A Multifaceted Intervention Designed to Improve Medical Management of Moderate to Advanced Chronic Kidney Disease in HIV-Infected Patients: A Cluster Randomized Trial. CLINICAL INFECTIOUS DISEASES, 61 (3), 375-384.
  • Abravanel F, Lhomme S, Chapuy-Regaud S, Peron JM, Alric L, Rostaing L, Kamar N, Izopet J. (2015). Performance of a new rapid test for detecting anti-hepatitis E virus immunoglobulin M in immunocompetent and immunocompromised patients. JOURNAL OF CLINICAL VIROLOGY, 70, 101-104.
  • Alanio A, Garcia-Hermoso D, Mercier-Delarue S, Lanternier F, Gits-Muselli M, Menotti J, Denis B, Bergeron A, Legrand M, Lortholary O, Bretagne S; French Mycosis Study Group. Molecular identification of Mucorales in human tissues: contribution of PCR electrospray-ionization mass spectrometry. (2015). Clin Microbiol Infect. 21(6):594.
  • Aubouy A, Olagnier D., Bertin Gwladys, Ezinmegnon S., Majorel Clarisse, Mimar S., Massougbodji A., Deloron Philippe, Pipy B, Coste A. (2015). Nrf2-driven CD36 and HO-1 gene expression in circulating monocytes correlates with favourable clinical outcome in pregnancy-associated malaria. Malaria Journal, 14.
  • Bailly F, Virlogeux V, Dufour C, Pradata P, Hezode C, Larrey D, Alric L, Samuel D, Bourliere M, Metivier S, Zarski JP, Fontaine H, Loustaud-Ratti V, Serfaty L, Bronowicki JP, Carrat F, Zoulim F. (2015). Early virological assessment during telaprevir- or boceprevir-based triple therapy in hepatitis C cirrhotic patients who failed a previous interferon based regimen – The ANRS CO20-CUPIC study. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 39 (4), 443-450.
  • Belliere J, Casemayou A, Ducasse L, Zakaroff-Girard A, Martins F, Iacovoni JS, Guilbeau-Frugier C, Buffin-Meyer B, Pipy B, Chauveau D, Schanstra JP, Bascands JL. (2015). Specific Macrophage Subtypes Influence the Progression of Rhabdomyolysis-Induced Kidney Injury. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 26 (6), 1363-1377.
  • Bourliere M., Bronowicki J. P., de Ledinghen V., Hezode C., Zoulim F., Mathurin P., Tran A., Larrey D. G., Ratziu V., Alric L., Hyland R. H., Jiang D. Y., Doehle B., Pang P. S., Symonds W. T., Subramanian G. M., McHutchison J. G., Marcellin P., Habersetzer F., Guyader D., Grange J. D., Loustaud-Ratti V., Serfaty L., Metivier S., Leroy V., Abergel A., Pol S. (2015). Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (sirius). Lancet Infectious Diseases, 15 (4), 397-404.
  • Carrieri M. P., Serfaty L., Vilotitch A., Winnock M., Poizot-Martin I., Loko M. A., Lions C., Lascoux-Combe C., Roux P., Salmon-Ceron D., Spire B., Dabis F., Anrs Co Hepavih Study Grp. (2015). Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH). Clinical Infectious Diseases, 61 (1), 40-48.
  • Coilly A., Dumortier J., Botta-Fridlund D., Latournerie M., Leroy V., Pageaux G. P., Agostini H., Giostra E., Moreno C., Roche B., Antonini T. M., Guillaud O., Lebray P., Radenne S., Saouli A. C., Calmus Y., Alric L., Debette-Gratien M., De Ledinghen V., Durand F., Duvoux C., Samuel D., Duclos-Vallee J. C. (2015). Multicenter Experience with Boceprevir or Telaprevir to Treat Hepatitis C Recurrence after Liver Transplantation: When Present Becomes Past, What Lessons for Future?. Plos One, 10 (9).
  • Culetto A, Bournet B, Haennig A, Alric L, Peron JM, Buscail L. (2015). Prospective evaluation of the aetiological profile of acute pancreatitis in young adult patients. DIGESTIVE AND LIVER DISEASE, 47 (7), 584-589.
  • Del Bello A., Congy-Jolivet N., Danjoux M., Muscari F., Lavayssiere L., Esposito L., Cardeau-Desangles I., Guitard J., Dorr G., Milongo D., Suc B., Duffas J. P., Alric L., Bureau C., Guilbeau-Frugier C., Rostaing L., Kamar N. (2015). De novo donor-specific anti-HLA antibodies mediated rejection in liver-transplant patients. Transplant International, 28 (12), 1371-1382.
  • Filisetti D., Sterkers Y., Brenier-Pinchart M. P., Cassaing S., Dalle F., Delhaes L., Pelloux H., Touafek F., Varlet-Marie E., Yera H., Candolfi E., Bastien P. (2015). Multicentric Comparative Assessment of the Bio-Evolution Toxoplasma gondii Detection Kit with Eight Laboratory-Developed PCR Assays for Molecular Diagnosis of Congenital Toxoplasmosis. Journal of Clinical Microbiology, 53 (1), 29-34.
  • Fontaine H., Hezode C., Zoulim F., Samuel D., Bourliere M., Haour G., Dorival-Mouly C., Leroy V., De Ledinghen V., Lucier S., Larrey D., Tran A., Metivier S., Benhamou Y., Hubert-Fouchard I., Habersetzer F., Marcellin P., Mathurin P., Alric L., Bronowicki J. P., Guyader D., Loustaud-Ratti V., Minello A., Riachi G., Rosa I., Simony M., Diallo A., Carrat F., Pol S., Anrs Afef Hepather Study Grp. (2015). Efficacy of the oral sofosbuvir-based combinations in hcv genotype 4-mono-infected patients from the french observational cohort anrs co22 hepather. Journal of Hepatology, 62 (2), S278-S
  • Hasseine L, Cassaing S, Robert-Gangneux F, Fillaux J, Marty P, Gangneux JP. (2015). High negative predictive value diagnostic strategies for the reevaluation of early antifungal treatment: A multicenter prospective trial in patients at risk for invasive fungal infections. 71 (2), 258-265.
  • Iriart X, Belval TC, Fillaux J, Esposito L, Lavergne RA, Cardeau-Desangles I, Roques O, Del Bello A, Cointault O, Lavayssiere L, Chauvin P, Menard S, Magnaval J-F, Cassaing S, Rostaing L, Kamar N, Berry A. (2015). Risk Factors of Pneumocystis Pneumonia in Solid Organ Recipients in the Era of the Common Use of Posttransplantation Prophylaxis. AMERICAN JOURNAL OF Transplantation, 15 (1), 190-199.
  • Lawitz E., Gane E., Pearlman B., Tam E., Ghesquiere W., Guyader D., Alric L., Bronowicki J. P., Lester L., Sievert W., Ghalib R., Balart L., Sund F., Lagging M., Dutko F., Shaughnessy M., Hwang P., Howe A. Y. M., Wahl J., Robertson M., Barr E., Haber B. (2015). Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous. Lancet, 385 (9973), 1075-1086.
  • Lefevre L, Authier H, Stein S, Majorel C, Couderc B, Dardenne C, Eddine MA, Meunier E, Bernad J, Valentin A, Pipy B, Schoonjans K, Coste A. (2015). LRH-1 mediates anti-inflammatory and antifungal phenotype of IL-13-activated macrophages through the PPAR gamma ligand synthesis. NATURE COMMUNICATIONS, 6, 6801.
  • Mehawej M, Rostaing L, Alric L, Del Bello A, Izopet J, Kamar N. Boceprevir-Based Triple Antiviral Therapy for Chronic Hepatitis C Virus Infection in Kidney-Transplant Candidates. (2015). J Transplant.159795.
  • Michot J. M., Canioni D., Driss H., Alric L., Cacoub P., Suarez F., Sibon D., Thieblemont C., Dupuis J., Terrier B., Feray C., Tilly H., Pol S., Leblond V., Settegrana C., Rabiega P., Barthe Y., Hendel-Chavez H., Nguyen-Khac F., Merle-Beral H., Berger F., Molina T., Charlotte F., Carrat F., Davi F., Hermine O., Besson C., Anrs Hc- Lympho-C Study Grp. (2015). Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study. American Journal of Hematology, 90 (3), 197-203.
  • Milongo D., Bascands J. L., Huart A., Esposito L., Breuil B., Moulos P., Siwy J., Ramirez-Torres A., Ribes D., Lavayssiere L., Del Bello A., Muscari F., Alric L., Bureau C., Rostaing L., Schanstra J. P., Kamar N. (2015). Pretransplant urinary proteome analysis does not predict development of chronic kidney disease after liver transplantation. Liver International, 35 (7), 1893-1901.
  • Perrin HB, Cintas P, Abravanel F, Gerolami R, d’Alteroche L, Raynal JN, Alric L, Dupuis E, Prudhomme L, Vaucher E, Couzigou R, Liversain JM, Bureau C, Vinel JP, Kamar N, Lzopet J, Peron JM. (2015). Neurologic Disorders in Immunocompetent Patients with Autochthonous Acute Hepatitis E. Emerging Infectious Diseases, 21 (11), 1928-1934.
  • Pol S., Bourliere M., Lucier S., De Ledinghen V., Zoulim F., Dorival-Mouly C., Metivier S., Larrey D., Tran A., Hezode C., Bronowicki J. P., Samuel D., Marcellin P., Zarski J. P., Minello A., Alric L., Trinchet J. C., Nahon P., Guyader D., Chazouilleres O., Riachi G., Loustaud-Ratti V., Causse X., Mathurin P., Hubert-Fouchard I., Rosa I., Benhamou Y., Gournay J., Raabe J. J., Raffi F., Petrov-Sanchez V., Diallo A., Fontaine H., Carrat F., Hepather Study Grp. (2015). Safety and efficacy of the combination daclatasvir-sofosbuvir in hcv genotype 1-mono-infected patients from the french observational cohort anrs co22 hepather. Journal of Hepatology, 62 (2), S258-S
  • Robert-Gangneux F., Sterkers Y., Yera H., Accoceberry I., Menotti J., Cassaing S., Brenier-Pinchart M. P., Hennequin C., Delhaes L., Bonhomme J., Villena I., Scherer E., Dalle F., Touafek F., Filisetti D., Varlet-Marie E., Pelloux H., Bastien P. (2015). Molecular Diagnosis of Toxoplasmosis in Immunocompromised Patients: a 3-Year Multicenter Retrospective Study. Journal of Clinical Microbiology, 53 (5), 1677-1684.
  • Tavitian S, Peron JM, Huguet F, Kamar N, Abravanel F, Beyne-Rauzy O, Oberic L, Faguer S, Alric L, Roussel M, Gaudin C, Ysebaert L, Huynh A, Recher C. (2015). Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies. EMERGING INFECTIOUS DISEASES, 21 (8), 1466-1469.
  • Trinchet JC, Bourcier V, Chaffaut C, Ahmed MA, Allam S, Marcellin P, Guyader D, Pol S, Larrey D, De Ledinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, Zarski JP, Goria O, Cales P, Peron JM, Alric L, Bourliere M, Mathurin P, Blanc JF, Abergel A, Serfaty L, Mallat A, Grange JD, Buffet C, Bacq Y, Wartelle C, Dao T, Benhamou Y, Pilette C, Silvain C, Christidis C, Capron D, Thiefin G, Hillaire S, Di Martino V, Nahon P, Chevret S. (2015). Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort). HEPATOLOGY, 62 (3), 737-750.
  • Zeuzem S, Flisiak R, Vierling JM, Mazur W, Mazzella G, Thongsawat S, Abdurakhmanov D, Van Kinh N, Calistru P, Heo J, Stanciu C, Gould M, Makara M, Hsu SJ, Buggisch P, Samuel D, Mutimer D, Nault B, Merz M, Bao W, Griffel LH, Brass C, Naoumov NV.  (2015). Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment-naive patients with chronic HCV genotype 1 infection (ESSENTIAL II). ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 42 (7), 829-844.





  • Almelli T., Nuel G., Bischoff E., Aubouy A, Elati M., Wang C. W., Dillies M. A., Coppee J. Y., Ayissi G. N., Basco Leonardo, Rogier C., Tuikue Ndam Nicaise, Deloron Philippe, Tahar Rachida. (2014). Differences in gene transcriptomic pattern of Plasmodium falciparum in children with cerebral malaria and asymptomatic carriers. Plos One, 9 (12).
  • Alric L., Bonnet D., Fort M. (2014). Association Between Female Sex, IL28B Genotype, but Also DQB1*0301 Allele and the Outcome of Acute Hepatitis C Virus Infection. Hepatology, 60 (6), 2127-2127.
  • Authier H, Billot K, Derudder E, Bordereaux D, Riviere P, Rodrigues-Ferreira S, Nahmias C, Baud V. (2014). IKK phosphorylates RelB to modulate its promoter specificity and promote fibroblast migration downstream of TNF receptors. Proceedings Of The National Academy Of Sciences Of The United States Of America, 111 (41), 14794-14799.
  • Bailly F., Virlogeux V., Dufour C., Pradat P., Hezode C., Larrey D. G., Alric L., Samuel D., Bourliere M., Metivier S., Zarski J. P., Fontaine H., Loustaud-Ratti V., Serfaty L., Bronowicki J. P., Petrov-Sanchez V., Carrat F., Zoulim F. (2014). Relevance of early virological assessment during triple therapy combining telaprevir or boceprevir with pegylated interferon/ribavirin in chronic hepatitis C patients – The ANRS CO20 CUPIC study. Hepatology, 60 (1), 687A-687A.
  • Berry A, Mone H, Iriart X, Mouahid G, Aboo O, Boissier J, Fillaux J, Cassaing S, Debuisson C, Valentin A, Mitta G, Theron A, Magnaval JF. (2014). Schistosomiasis Haematobium, Corsica, France. Emerging Infectious Diseases, 20 (9), 1595-1597.
  • Cabanillas B. J., Le Lamer A. C., Olagnier D., Castillo D., Arevalo J., Valadeau C., Coste A., Pipy B., Bourdy G, Sauvain M, Fabre N. (2014). Leishmanicidal compounds and potent PPAR gamma activators from Renealmia thyrsoidea (Ruiz & Pav.) Poepp. & Endl. Journal of Ethnopharmacology, 157, 149-155.
  • Carrieri M. P., Lions C., Sogni P., Winnock M., Roux P., Mora M., Bonnard P., Salmon D., Dabis F., Spire B., Anrs Co Hepavih Study Grp. (2014). Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: Results from the ANRS CO13 HEPAVIH cohort study. Journal of Hepatology, 60 (1), 46-53.
  • Comont T, Bonnet D, Sigur N, Gerdelat A, Legrand-Abravanel F, Kamar N, Alric L. (2014). Acute hepatitis E infection associated with Guillain-Barre syndrome in an immunocompetent patient. Revue De Medecine Interne, 35 (5), 333-336.
  • Dahlstrom S., Aubouy A, Maiga-Ascofare O., Faucher J. F., Wakpo A., Ezinmegnon S., Massougbodji A., Houze P., Kendjo E., Deloron Philippe, Le Bras J., Houze S. (2014). Plasmodium falciparum polymorphisms associated with ex vivo drug susceptibility and clinical effectiveness of artemisinin-based combination therapies in Benin. Antimicrobial Agents and Chemotherapy, 58 (1), 1-10.
  • Del Bello A., Congy-Jolivet N., Muscari F., Lavayssiere L., Esposito L., Cardeau-Desangles I., Guitard J., Dorr G., Suc B., Duffas J. P., Alric L., Bureau C., Danjoux M., Guilbeau-Frugier C., Blancher A., Rostaing L., Kamar N. (2014). Prevalence, Incidence and Risk Factors for Donor-Specific Anti-HLA Antibodies in Maintenance Liver Transplant Patients. American Journal of Transplantation, 14 (4), 867-875.
  • Delhaes L., Filisetti D., Brenier-Pinchart M. P., Pelloux H., Yera H., Dalle F., Sterkers Y., Varlet-Marie E., Touafek F., Cassaing S., Bastien P. (2014). Freezing and storage at -20 degrees C provides adequate preservation of Toxoplasma gondii DNA for retrospective molecular analysis. Diagnostic Microbiology and Infectious Disease, 80 (3), 197-199.
  • Fillaux J., Bremont F., Murris M., Cassaing S., Tetu L., Segonds C., Pipy B., Magnaval J. F. (2014). Aspergillus Sensitization or Carriage in Cystic Fibrosis Patients. Pediatric Infectious Disease Journal, 33 (7), 680-686.
  • Geri G., Maynard M., Rosenthal E., Fontaine H., Lacombe K., Slama L., Goujard C., Loustaud-Ratti V., Bergmann J. F., Morlat P., Vittecoq D., Alric L., Cacoub P., Germivic Grp. (2014). Care of hepatitis C virus infection in France: modifications in three consecutive surveys between 1995 and Liver International, 34 (9), 1349-1357.
  • Hezode C., Fontaine H., Dorival C., Zoulim F., Larrey D., Canva V., De Ledinghen V., Poynard T., Samuel D., Bourliere M., Alric L., Raabe J. J., Zarski J. P., Marcellin P., Riachi G., Bernard P. H., Loustaud-Ratti V., Chazouilleres O., Abergel A., Guyader D., Metivier S., Tran A., Di Martino V., Causse X., Dao T., Lucidarme D., Portal I., Cacoub P., Gournay J., Grando-Lemaire V., Hillon P., Attali P., Fontanges T., Rosa I., Petrov-Sanchez V., Barthe Y., Pawlotsky J. M., Pol S., Carrat F., Bronowicki J. P., Cupic Study Grp. (2014). Effectiveness of Telaprevir or Boceprevir in Treatment-Experienced Patients With HCV Genotype 1 Infection and Cirrhosis. Gastroenterology, 147 (1), 132-U
  • Iriart X, Blanchet D, Menard S, Lavergne RA, Chauvin P, Adenis A, Cassaing S, Fillaux J, Magnaval JF, Demar M, Carme B, Bessieres MH, Couppie P, Nacher M, Berry A, Aznar C. (2014). A complementary tool for management of disseminated Histoplasma capsulatum var. capsulatum infections in AIDS patients. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 304 (8), 1062-1065.
  • Jourand P, Hannibal L, Majorel C, Mengant S., Ducousso M., Lebrun M. (2014). Ectomycorrhizal Pisolithus albus inoculation of Acacia spirorbis and Eucalyptus globulus grown in ultramafic topsoil enhances plant growth and mineral nutrition while limits metal uptake. Journal of Plant Physiology, 171 (2), 164-172.
  • Julia M., Gandia P., Guivarch M., Coimet-Berger L., Abravanel F., Bonnet D., Alric L. (2014). Influence of ribavirin plasma concentration on the virological response and safety in patients with HCV genotype 1 infection treated by combination therapy with telaprevir or boceprevir. Hepatology, 60 (1), 695A-695A.
  • Lavergne R. A., Iriart X., Martin-Blondel G., Chauvin P., Menard S., Fillaux J., Cassaing S., Roques-Malecaze C., Arnaud S., Valentin A., Magnaval J. F., Marchou B., Berry A. (2014). Contribution of molecular diagnosis to the management of cutaneous leishmaniasis in travellers. Clinical Microbiology and Infection, 20 (8), O528-O
  • Lawitz E., Gane E. J., Pearlman B., Tam E., Ghesquiere W., Guyader D., Alric L., Bronowicki J. P., Rossaro L., Sievert W., Ghalib R. H., Balart L. A., Sund F., Lagging M., Dutko F., Howe A. Y., Shaughnessy M., Hwang P., Wahl J., Robertson M., Haber B. A. (2014). Efficacy and safety of MK-5172 and MK-8742 +/- ribavirin in hepatitis C genotype 1 infected patients with cirrhosis or previous null response: Final results of the C-WORTHY Study (Parts A and B). Hepatology, 60 (1), 296A-297A.
  • Le Lamer A. C., Authier H., Rouaud I., Coste A., Boustie J., Pipy B., Gouault N. (2014). Protolichesterinic acid derivatives: alpha-Methylene-gamma-lactones as potent dual activators of PPAR gamma and Nrf2 transcriptional factors. Bioorganic & Medicinal Chemistry Letters, 24 (16), 3819-3822.
  • Picard M, Cassaing S, Letocart P, Verdeil X, Protin C, Chauvin P, Iriart X, Cavalie L, Valentin A, Marchou B, Ruiz J, Riu-Poulenc B, Huguet F, Recher C. (2014). Concomitant cases of disseminated Geotrichum clavatum infections in patients with acute myeloid leukemia. LEUKEMIA & LYMPHOMA, 55 (5), 1186-1188.
  • Sanchez C, Diab DE, Connord V, Clerc P, Meunier E, Pipy B, Payre B, Tan RP, Gougeon M, Carrey J, Gigoux V, Fourmy D. (2014). Targeting A G-Protein Coupled Receptor Overexpressed In Endocrine Tumors By Magnetic Nanoparticles To Induce Cell Death. Journal Of Molecular Neuroscience, 53, S173-S
  • Sigur N, Alric L, Chiavassa H, Mourguet M, Bonnet D. (2014). Abdominal pain of unusual cause. REVUE DE MEDECINE INTERNE, 35 (9), 626-627.
  • Varlet-Marie E, Sterkers Y, Brenier-Pinchart MP, Cassaing S, Dalle F, Delhaes L, Filisetti D, Pelloux H, Touafek F, Yera H, Bastien P. (2014). Characterization and Multicentric Validation of a Common Standard for Toxoplasma gondii Detection Using Nucleic Acid Amplification Assays. JOURNAL OF CLINICAL MICROBIOLOGY, 52 (11), 3952-3959.
  • Yalcindag E., Rougeron V., Elguero Eric, Arnathau C., Durand P., Brisse S., Diancourt L., Aubouy A, Becquart P, d’Alessandro U., Fontenille Didier, Gamboa D., Maestre A., Menard D., Musset L., Noya O., Veron V., Wide A., Carme B., Legrand E., Chevillon C., Ayala F. J., Renaud F., Prugnolle Franck.  (2014). Patterns of selection on Plasmodium falciparum erythrocyte-binding antigens after the colonization of the New World. Molecular Ecology, 23 (8), 1979-1993.





  • Abravanel F, Chapuy-Regaud S, Lhomme S, Dubois M, Peron JM, Alric L, Rostaing L, Kamar N, Izopet J. (2013). Performance of Two Commercial Assays for Detecting Hepatitis E Virus RNA in Acute or Chronic Infections. JOURNAL OF CLINICAL MICROBIOLOGY, 51 (6), 1913-1916.
  • Abravanel F, Chapuy-Regaud S, Lhomme S, Miedouge M, Peron JM, Alric L, Rostaing L, Kamar N, Izopet J. (2013). Performance of anti-HEV assays for diagnosing acute hepatitis E in immunocompromised patients. JOURNAL OF CLINICAL VIROLOGY, 58 (4), 624-628.
  • Abravanel F, Lhomme S, Dubois M, Peron JM, Alric L, Kamar N, Izopet J. (2013). Hepatitis E virus. MEDECINE ET MALADIES INFECTIEUSES, 43 (7), 263-270.
  • Alric L., Guivarch M., Berard E., Metivier S., Barange K., Nicot F., Abravanel F., Bonnet D. (2013). Sustained virologic esponse to Telaprevir or Boceprevir in previously non responder HCV genotype 1 patients with severe liver fibrosis: results of a prospective multicentric study. Hepatology, 58 (1), 1154A-1155A.
  • Cardeau-Desangles I, Fabre A, Cointault O, Guitard J, Esposito L, Iriart X, Berry A, Valentin A, Cassaing S, Kamar N. (2013). Disseminated Ochroconis gallopava infection in a heart transplant patient. TRANSPLANT INFECTIOUS DISEASE, 15 (3), E115-E
  • Dardenne C., Lefevre L., Meunier E., Eddine M. A., Bernad J., Minville-Walz M., Bouschbacher M., Coste A., Pipy B. (2013). Modulation of arachidonic acid metabolism accelerates impaired cutaneous wound healing in diabetic mice. Wound Repair and Regeneration, 21 (6), A62-A
  • Devillers A., Courjol F., Fradin C., Coste A., Poulain D., Pipy B., Bernardes E. S., Jouault T. (2013). Deficient Beta-Mannosylation of Candida albicans Phospholipomannan Affects the Proinflammatory Response in Macrophages. Plos One, 8 (12).
  • Duggal P, Thio CL, Wojcik GL, Goedert JJ, Mangia A, Latanich R, Kim AY, Lauer GM, Chung RT, Peters MG, Kirk GD, Mehta SH, Cox AL, Khakoo SI, Alric L, Cramp ME, Donfield SM, Edlin BR, Tobler LH, Busch MP, Alexander G, Rosen HR, Gao XJ, Abdel-Hamid M, Apps R, Carrington M, Thomas DL. (2013). Genome-Wide Association Study of Spontaneous Resolution of Hepatitis C Virus Infection: Data From Multiple Cohorts. Annals Of Internal Medicine, 158 (4), 235-245.
  • Fillaux J, and Berry A. Real-time PCR assay for the diagnosis of Pneumocystis jirovecii pneumonia. Methods Mol Biol. 2013, 943, 159-70.
  • Fillaux J., Magnaval J. F. (2013). Laboratory diagnosis of human toxocariasis. Veterinary Parasitology, 193 (4), 327-336.
  • Fontaine H., Alric L., Salleron J., Antoine C., Legendre C. M., Hazan M., Kamar N., Pol S., Duhamel A., Mathurin P. (2013). Updated evaluation of the prognostic impact of Hepatitis B and C infections in kidney recipients. Hepatology, 58 (1), 610A-611A.
  • Hezode C., Fontaine H., Dorival C., Larrey D., Zoulim F., Canva V., de Ledinghen V., Poynard T., Samuel D., Bourliere M., Zarski J. P., Raabe J. J., Alric L., Marcellin P., Riachi G., Bernard P. H., Loustaud-Ratti V., Metivier S., Tran A., Serfaty L., Abergel A., Causse X., Di Martino V., Guyader D., Lucidarme D., Grando-Lemaire V., Hillon P., Feray C., Dao T., Cacoub P., Rosa I., Attali P., Petrov-Sanchez V., Barthe Y., Pawlotsky J. M., Pol S., Carrat F., Bronowicki J. P., Cupic Study Grp. (2013). Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS co20-cupic)-nct Journal of Hepatology, 59 (3), 434-441.
  • Jacque E, Billot K, Authier H, Bordereaux D, Baud V. (2013). RelB inhibits cell proliferation and tumor growth through p53 transcriptional activation. ONCOGENE, 32 (21), 2661-2669.
  • Kamar N., Alric L., Izopet J., Rostaing L. (2013). Hepatitis C virus and kidney disease. Clinics and Research in Hepatology and Gastroenterology, 37 (4), 328-333.
  • Lavergne R. A., Chauvin P., Valentin A., Fillaux J., Roques-Malecaze C., Arnaud S., Menard S., Magnaval J. F., Berry A., Cassaing S., Iriart X. (2013). An extraction method of positive blood cultures for direct identification of Candida species by Vitek MS matrix-assisted laser desorption ionization time of flight mass spectrometry. Medical Mycology, 51 (6), 652-656.
  • Lefevre L., Lugo-Villarino G., Meunier E., Valentin A., Olagnier D., Authier H., Duval C., Dardenne C., Bernad J., Lemesre Jean-Loup, Auwerx J., Neyrolles O., Pipy B., Coste A. (2013). The C-type lectin receptors dectin-1, MR, and SIGNR3 contribute both positively and negatively to the macrophage response to Leishmania infantum. Immunity, 38 (5), 1038-1049.
  • Nguyen H. Y. T., Vo B. H. T., Nguyen L. T. H., Bernad J., Alaeddine M., Coste A., Reybier K., Pipy B., Nepveu F.  (2013). Extracts of Crinum latifolium inhibit the cell viability of mouse lymph oma cell line EL4 and Induce activation of anti-tumour activity of macrophages in vitro. Journal of Ethnopharmacology, 149 (1), 75-83.





  • Abravanel F, Mansuy JM, Huynh A, Kamar N, Alric L, Peron JM, Recher C, Izopet J. (2012). Low risk of hepatitis E virus reactivation after haematopoietic stem cell transplantation. Journal Of Clinical Virology, 54 (2), 152-155.
  • Al-Kattan A, Girod-Fullana S, Charvillat C, Ternet-Fontebasso H, Dufour P, Dexpert-Ghys J, Santran V, Bordere J, Pipy B, Bernad J, Drouet C. (2012). Biomimetic nanocrystalline apatites: Emerging perspectives in cancer diagnosis and treatment. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 423 (1), 26-36.
  • Bonnet D, Kamar N, Izopet J, Alric L. (2012). Hepatitis E: An emerging disease. REVUE DE MEDECINE INTERNE, 33 (6), 328-334.
  • Bonnet D, Selves J, Toulas C, Danjoux M, Duffas JP, Portier G, Kirzin S, Ghouti L, Carrere N, Suc B, Alric L, Barange K, Buscail L, Chaubard T, Imani K, Guimbaud R. (2012). Simplified identification of Lynch syndrome: A prospective, multicenter study. Digestive And Liver Disease, 44 (6), 515-522.
  • Bourcier V, Winnock M, Ahmed MA, Sogni P, Pambrun E, Poizot-Martin I, Chaffaut C, Chevret S, Trinchet JC, Salmon D. (2012). Primary liver cancer is more aggressive in HIV-HCV coinfection than in HCV infection. A prospective study (ANRS CO13 Hepavih and CO12 Cirvir). Clinics And Research In Hepatology And Gastroenterology, 36 (3), 214-221.
  • Brevet français N 1262644, déposé le 21 décembre 2012; Utilisation acide acétyl salicylique pour la prévention et/ou le traitement des plaies du diabétique. Agnès Coste, Bernard Pipy, Christophe Dardenne.
  • Dannaoui E, Desnos-Ollivier M, Garcia-Hermoso D, Grenouillet F, Cassaing S, Baixench MT, Bretagne S, Dromer F, Lortholary O. (2012). Candida spp. with Acquired Echinocandin Resistance, France, 2004-2010. EMERGING INFECTIOUS DISEASES, 18 (1), 86-90.
  • Fillaux J., Bremont F., Murris M., Cassaing S., Rittie J. L., Tetu L., Segonds C., Abbal M., Bieth E., Berry A., Pipy B., Magnaval J. F. (2012). Assessment of Aspergillus sensitization or persistent carriage as a factor in lung function impairment in cystic fibrosis patients. Scandinavian Journal of Infectious Diseases, 44 (11), 842-847.
  • Ibrahim H., Furiga A., Najahi E., Henocq C. P., Nallet J. P., Roques C., Aubouy A, Sauvain M, Constant P., Daffe M., Nepveu F. (2012). Antibacterial, antifungal and antileishmanial activities of indolone-N-oxide derivatives. Journal of Antibiotics, 65 (10), 499-504.
  • Iriart X, Lavergne RA, Fillaux J, Valentin A, Magnaval JF, Berry A, Cassaing S. Performances du spectromètre de masse VITEKMS (MALDI-TOF) pour l'identification des espèces fongiques isolées en routine au CHU de Toulouse. J. Mycol. med. 2012, 22: 277-8.
  • Iriart X., Lavergne R. A., Fillaux J., Valentin A., Magnaval J. F., Berry A., Cassaing S. (2012). Routine Identification of Medical Fungi by the New Vitek MS Matrix-Assisted Laser Desorption Ionization-Time of Flight System with a New Time-Effective Strategy. Journal of Clinical Microbiology, 50 (6), 2107-2110.
  • Kamar N, Weclawiak H, Guilbeau-Frugier C, Legrand-Abravanel F, Cointault O, Ribes D, Esposito L, Cardeau-Desangles I, Guitard J, Sallusto F, Muscari F, Peron JM, Alric L, Izopet J, Rostaing L. (2012). Hepatitis E Virus and the Kidney in Solid-Organ Transplant Patients. TRANSPLANTATION, 93 (6), 617-623.
  • Lavergne R. A., Cassaing S., Nocera T., Pauwels C., Cointault O., Basse G., Lavayssiere L., Berry A., Kamar N., Lamant L., Iriart X., Linas M. D., Valentin A., Fillaux J., Paul C., Magnaval J. F. (2012). Simultaneous cutaneous infection due to Paecilomyces lilacinus and Alternaria in a heart transplant patient. Transplant Infectious Disease, 14 (6), E156-E
  • Matsui M., Adib-Conquy M., Coste A., Kumar-Roine S., Pipy B., Laurent , Pauillac S. (2012). Aqueous extract of Vitex trifolia L. (Labiatae) inhibits LPS-dependent regulation of inflammatory mediators in RAW 264.7 macrophages through inhibition of Nuclear Factor kappa B translocation and expression. Journal of Ethnopharmacology, 143 (1), 24-32.
  • Mavigner M, Cazabat M, Dubois M, L’Faqihi FE, Requena M, Pasquier C, Klopp P, Amar J, Alric L, Barange K, Vinel JP, Marchou B, Massip P, Izopet J, Delobel P. (2012). Altered CD4(+) T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals. JOURNAL OF CLINICAL INVESTIGATION, 122 (1), 62-69.
  • Ménard S., Morlais Isabelle, Tahar Rachida, Sayang C., Mayengue P. I., Iriart X., Benoit-Vical F., Lemen B., Magnaval J. F., Awono-Ambene P., Basco Leonardo, Berry A. (2012). Molecular monitoring of Plasmodium falciparum drug susceptibility at the time of the introduction of artemisinin-based combination therapy in Yaounde, Cameroon: implications for the future. Malaria Journal, 11.
  • Meunier E., Coste A., Olagnier D., Authier H., Lefevre L., Dardenne C., Bernad J., Beraud M., Flahaut E., Pipy B. (2012). Double-walled carbon nanotubes trigger IL-1 beta release in human monocytes through Nlrp3 inflammasome activation. Nanomedicine-Nanotechnology Biology and Medicine, 8 (6), 987-995.
  • Miravete M, Dissard R, Klein J, Gonzalez J, Caubet C, Pecher C, Pipy B, Bascands JL, Mercier-Bonin M, Schanstra JP, Buffin-Meyer B. (2012). Renal tubular fluid shear stress facilitates monocyte activation toward inflammatory macrophages. American Journal Of Physiology-Renal Physiology, 302 (11), F1409-F
  • Morelle C, Varlet-Marie E, Brenier-Pinchart MP, Cassaing S, Pelloux H, Bastien P, Sterkers Y. (2012). Comparative Assessment of a Commercial Kit and Two Laboratory-Developed PCR Assays for Molecular Diagnosis of Congenital Toxoplasmosis. JOURNAL OF CLINICAL MICROBIOLOGY, 50 (12), 3977-3982.
  • Pressanti C., Delverdier M., Iriart X., Morcel F., Cadiergues M. C. (2012). A case of Trichophyton mentagrophytes infection in a fennec fox (Vulpes zerda). Veterinary Dermatology, 23 (5).
  • Rivoisy C, Gerard L, Boutboul D, Malphettes M, Fieschi C, Durieu I, Tron F, Masseau A, Bordigoni P, Alric L, Haroche J, Hoarau C, Berezne A, Carmagnat M, Mouillot G, Oksenhendler E. (2012). Parental Consanguinity is Associated with a Severe Phenotype in Common Variable Immunodeficiency. JOURNAL OF CLINICAL IMMUNOLOGY, 32 (1), 98-105.
  • Soh P. N., Witkowski B., Gales A., Huyghe E., Berry A., Pipy B., Benoit-Vical F. (2012). Implication of Glutathione in the In Vitro Antiplasmodial Mechanism of Action of Ellagic Acid. Plos One, 7 (9).
  • Witkowski B., Lelievre J., Nicolau-Travers M. L., Iriart X., Soh P. N., Bousejra-ElGarah F., Meunier B., Berry A., Benoit-Vical F. (2012). Evidence for the Contribution of the Hemozoin Synthesis Pathway of the Murine Plasmodium yoelii to the Resistance to Artemisinin-Related Drugs. Plos One, 7 (3).
  • Yalcindag E., Elguero Eric, Arnathau C., Durand P., Akiana J., Anderson T. J., Aubouy A, Balloux F., Besnard P., Bogreau H., Carnevale P., D’Alessandro U., Fontenille Didier, Gamboa D., Jombart T., Le Mire J., Leroy Eric, Maestre A., Mayxay M., Menard D., Musset L., Newton P. N., Nkoghe D., Noya O., Ollomo B., Rogier C., Veron V., Wide A., Zakeri S., Carme B., Legrand E., Chevillon C., Ayala F. J., Renaud F., Prugnolle F.  (2012). Multiple independent introductions of Plasmodium falciparum in South America. Proceedings of the National Academy of Sciences of the United States of America, 109 (2), 511-516.



 

 

 

ACTUALITÉS

Evaluation HCERES

18 juillet 2019

Pharmadev fait partie des structures de recherche évaluées pour le quinquennal 2014-2018 au cours de la vague A HCERES. Le dossier...


Triste nouvelle : décès de Monsieur Moulis

15 juillet 2019

Notre collègue le Pr Claude Moulis, professeur émérite dans notre unité, nous a quitté jeudi des suites d'un cancer. La pharmacognosie...


Bravo à Stéphane pour son HDR!!

15 juillet 2019

Stéphane Bertani a brillament soutenu et obtenu son HDR le 27 mai dernier. Encore bravo!!


Karine Reybier promue Professeur des Universités

9 juillet 2019

Bravo à Karine pour sa promotion de prof!! Après avoir obtenu la qualification 85ème section en 2015, Karine Reybier sera promue...


Concours IRD chercheurs – résultats phase d’admissibilité

9 juillet 2019

La campagne 2019 des concours chercheurs à l’IRD est terminée. Pour la CSS2 (Sciences biologiques et médicales), il y avait cette...

Tout afficher